Bridgewater Associates’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,242
Closed -$413K 1133
2026
Q1
$413K Sell
37,242
-2,187,368
-98% -$27.9M ﹤0.01% 914
2025
Q4
$36.5M Sell
2,224,610
-271,015
-11% -$4.22M 0.13% 124
2025
Q3
$33.4M Buy
2,495,625
+97,357
+4% +$1.15M 0.13% 129
2025
Q2
$30.7M Buy
2,398,268
+58,934
+3% +$707K 0.12% 130
2025
Q1
$24.1M Buy
2,339,334
+1,192,280
+104% +$15.3M 0.11% 156
2024
Q4
$14.6M Buy
1,147,054
+662,788
+137% +$8.76M 0.07% 202
2024
Q3
$6.2M Sell
484,266
-70,018
-13% -$857K 0.04% 342
2024
Q2
$7.03M Buy
554,284
+533,445
+2,560% +$9.22M 0.04% 305
2024
Q1
$472K Buy
+20,839
New +$488K ﹤0.01% 630

Other funds holding PATH

Bridgewater Associates's PATH Position: Q2 2026 in Review

Bridgewater Associates sold out of UiPath (PATH) in Q2 2026, closing a stake of 37,242 shares — an estimated $413K sold.

Bridgewater Associates first reported a position in PATH in Q1 2024 and held it in 9 quarters. The position peaked at $36.5M in Q4 2025. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Bridgewater Associates reported no remaining UiPath position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Associates sold 37,242 UiPath shares in Q2 2026, an estimated $413K.
  • Bridgewater Associates first reported a position in UiPath in Q1 2024 and held it in 9 quarters.
  • Bridgewater Associates's UiPath position peaked at $36.5M in Q4 2025.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.